Zobrazeno 1 - 10
of 178
pro vyhledávání: '"O. Csuka"'
Autor:
M Bak, J. Pozsár, Zsolt Tulassay, Barna Wichmann, G. Ivády, Ákos Pap, M Burai, N Le, J. Fillinger, Béla Molnár, R Szmola, Zsófia Brigitta Nagy, Á Tarpay, S Szanyi, O. Csuka
Publikováno v:
Pancreatology. 19:873-879
Background/Objectives Malignant pancreatobiliary strictures are in many cases clinically indistinguishable and present a major problem to endoscopy specialists. Intraductal sampling procedures such as brush cytology are commonly used for diagnosis wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e721e3795bbf1372a0006b1b86f779
https://doi.org/10.1016/j.pan.2019.04.001
https://doi.org/10.1016/j.pan.2019.04.001
Publikováno v:
Clinical and Experimental Metastasis. 18:639-649
The organ-specific metastasis characterizes several human cancers, including colon carcinoma, a disease that frequently involves metastases in the liver. The data on the molecular mechanisms of liver metastasis would therefore be highly useful for pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::764bb21d08eaf1703e78fcd0a6a37ac2
https://doi.org/10.1023/a:1013136303880
https://doi.org/10.1023/a:1013136303880
Autor:
Zs. Vadász, I. Mezo, Tibor Vántus, M. Idei, Aniko Horvath, Á. Balogh, O. Csuka, K. Pal, Gy. Kéri, I. Teplan, Judit Horvath, Marianna Mák
Publikováno v:
Biochemical and Biophysical Research Communications. 191:681-687
A series of new somatostatin analogs have been developed and tested for antitumor activity. Some analogs strongly inhibited tyrosine kinase activity of human colon tumor cells and this activity correlated well with their antiproliferative effect, but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cabad93dcee74024303848acf94324bf
https://doi.org/10.1006/bbrc.1993.1271
https://doi.org/10.1006/bbrc.1993.1271
Autor:
Anikó Horváth, Robert Ian Nicholson, Zs. Vadász, Judit Horvath, Agnes Balogh, Tamas Bajor, Gy. Kéri, Istvan Teplan, Tibor Vántus, O. Csuka, Gy. Bökönyi, I. Mezö
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 43:105-110
A series of novel gonadotropin releasing hormone (GnRH) and Somatostatin analogs have been developed in our laboratory and were screened for antiproliferative and signal transduction inhibitory effect. Our GnRH analog Folligen, had significant antitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1e4b85c5981cc6cb23726fc4805415
https://doi.org/10.1016/0960-0760(92)90193-m
https://doi.org/10.1016/0960-0760(92)90193-m
Autor:
G. Peley, Attila Bezzegh, B. Schumann, O. Csuka, I Besznyák, I Péter, J Tóth, I. Szamel, Szabolcs Ottó, Z. Doleschall
Publikováno v:
Europe PubMed Central
In this prospective study the correlation of pathological with biological prognostic factors and serum tumor markers has been investigated in 574 patients with primary invasive breast cancer. The p53 protein and Bax level correlated positively with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef21a038b7d20756eacdbd41dafddda2
https://doi.org/10.1177/172460089901400110
https://doi.org/10.1177/172460089901400110
Publikováno v:
Anticancer research. 28(5A)
The somatostatin structural derivative, TT-232, has a special 5-residue ring structure (D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2) and very different characteristics from the known growth hormone (GH) active somatostatin analogs. This somatostatin structur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6cc3473908805b36762582b5de7787dc
https://pubmed.ncbi.nlm.nih.gov/19035308
https://pubmed.ncbi.nlm.nih.gov/19035308
Publikováno v:
Anticancer research. 26(4B)
The tumor growth inhibitory efficacy of the somatostatin structural derivative TT-232 was studied using different routes of administration and treatment schedules in various human tumor models. TT-232, containing a five-residue ring structure, has a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb9eb2abce0b75294060daf02370b0e0
https://pubmed.ncbi.nlm.nih.gov/16886628
https://pubmed.ncbi.nlm.nih.gov/16886628
Publikováno v:
Anticancer research. 25(1A)
TT-232 is a structural derivative of the natural signal inhibitory peptide somatostatin, with selective antiproliferative and anti-inflammatory properties. TT-232 activates SSTR receptors (primarily the SSTR-1), which leads to irreversible cell cycle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3b8e58e81c650a5d0bd926c047ec811c
https://pubmed.ncbi.nlm.nih.gov/15816555
https://pubmed.ncbi.nlm.nih.gov/15816555
Publikováno v:
In vivo (Athens, Greece). 19(2)
The drug accumulation of a human multidrug resistance 1 (mdr1) gene-transfected mouse lymphoma cell line and a multidrug resistance protein (MRP)-expressing human breast cancer cell line MDA-MB-231 was compared in the presence of sixteen flavonoids a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c6a1a6b79f99e79fc05892e6b9558987
https://pubmed.ncbi.nlm.nih.gov/15796199
https://pubmed.ncbi.nlm.nih.gov/15796199
Publikováno v:
Anticancer research. 23(5A)
A somatostatin structural derivative (TT-232) has been developed in our laboratory with strong antiproliferative effect but no GH- release inhibitory activity. TT-232 inhibited tyrosine kinase activity of tumor cells lines and this inhibition correla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2478b8cbf96d6e9dbfd2ec5f18172c5
https://pubmed.ncbi.nlm.nih.gov/14666719
https://pubmed.ncbi.nlm.nih.gov/14666719